Literature DB >> 20584945

Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?

Charles Pierrot-Deseilligny1, Jean-Claude Souberbielle.   

Abstract

The role of hypovitaminosis D as a possible risk factor for multiple sclerosis is reviewed. First, it is emphasized that hypovitaminosis D could be only one of the risk factors for multiple sclerosis and that numerous other environmental and genetic risk factors appear to interact and combine to trigger the disease. Secondly, the classical physiological notions about vitamin D have recently been challenged and the main new findings are summarized. This vitamin could have an important immunological role involving a number of organs and pathologies, including autoimmune diseases and multiple sclerosis. Furthermore, human requirements for this vitamin are much higher than previously thought, and in medium- or high-latitude countries, they might not be met in the majority of the general population due to a lack of sunshine and an increasingly urbanized lifestyle. Thereafter, the different types of studies that have helped to implicate hypovitaminosis D as a risk factor for multiple sclerosis are reviewed. In experimental autoimmune encephalomyelitis, vitamin D has been shown to play a significant immunological role. Diverse epidemiological studies suggest that a direct chain of causality exists in the general population between latitude, exposure to the sun, vitamin D status and the risk of multiple sclerosis. New epidemiological analyses from France support the existence of this chain of links. Recently reported immunological findings in patients with multiple sclerosis have consistently shown that vitamin D significantly influences regulatory T lymphocyte cells, whose role is well known in the pathogenesis of the disease. Lastly, in a number of studies on serum levels of vitamin D in multiple sclerosis, an insufficiency was observed in the great majority of patients, including at the earliest stages of the disease. The questionable specificity and significance of such results is detailed here. Based on a final global analysis of the cumulative significance of these different types of findings, it would appear likely that hypovitaminosis D is one of the risk factors for multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20584945     DOI: 10.1093/brain/awq147

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  42 in total

Review 1.  [The genetic profile of multiple sclerosis: risk genes and the "dark matter"].

Authors:  C M Lill; F Zipp
Journal:  Nervenarzt       Date:  2012-06       Impact factor: 1.214

2.  Are the prevalence and incidence of multiple sclerosis changing?

Authors:  Julián Benito-León
Journal:  Neuroepidemiology       Date:  2011-04-20       Impact factor: 3.282

3.  The Effect of Vitamin D and Calcium plus Vitamin D during Pregnancy on Pregnancy and Birth Outcomes: a Randomized Controlled Trial.

Authors:  Sakineh Mohammad-Alizadeh-Charandabi; Mojgan Mirghafourvand; Ameneh Mansouri; Moslem Najafi; Farzane Khodabande
Journal:  J Caring Sci       Date:  2015-03-01

4.  Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.

Authors:  Egil Røsjø; Linn H Steffensen; Lone Jørgensen; Jonas C Lindstrøm; Jūratė Šaltytė Benth; Annika E Michelsen; Pål Aukrust; Thor Ueland; Margitta T Kampman; Øivind Torkildsen; Trygve Holmøy
Journal:  J Neurol       Date:  2015-10-01       Impact factor: 4.849

Review 5.  Role of vitamin D in immune responses and autoimmune diseases, with emphasis on its role in multiple sclerosis.

Authors:  Hong-Liang Zhang; Jiang Wu
Journal:  Neurosci Bull       Date:  2010-12       Impact factor: 5.203

Review 6.  The neuropathology of obesity: insights from human disease.

Authors:  Edward B Lee; Mark P Mattson
Journal:  Acta Neuropathol       Date:  2013-10-06       Impact factor: 17.088

7.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

8.  Promoting return of function in multiple sclerosis: An integrated approach.

Authors:  Mar Gacias; Patrizia Casaccia
Journal:  Mult Scler Relat Disord       Date:  2013-10-01       Impact factor: 4.339

9.  EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.

Authors:  Ahmad Nejati; Zabihollah Shoja; Shohreh Shahmahmoodi; Abbas Tafakhori; Yaghoub Mollaei-Kandelous; Farhad Rezaei; Kabir Magaji Hamid; Abbas Mirshafiey; Rozita Doosti; Mohammad Ali Sahraian; Mahmood Mahmoudi; Fazel Shokri; Vince Emery; Sayed Mahdi Marashi
Journal:  Med Microbiol Immunol       Date:  2015-09-13       Impact factor: 3.402

Review 10.  Vitamin D and Genetic Susceptibility to Multiple Sclerosis.

Authors:  Concetta Scazzone; Luisa Agnello; Giulia Bivona; Bruna Lo Sasso; Marcello Ciaccio
Journal:  Biochem Genet       Date:  2020-11-07       Impact factor: 1.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.